Obesity in Pulmonary Arterial Hypertension The Pulmonary Hypertension Association Registry

Rationale: Obesity is associated with pulmonary arterial hypertension (PAH), but its impact on outcomes such as health-related quality of life (HRQoL), hospitalizations, and survival is not well understood. Objectives: To assess the effect of obesity on HRQoL, hospitalizations, and survival in patie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ANNALS OF THE AMERICAN THORACIC SOCIETY 2021-02, Vol.18 (2), p.229-237
Hauptverfasser: Min, Jeff, Feng, Rui, Badesch, David, Berman-Rosenzweig, Erika, Burger, Charles, Chakinala, Murali, De Marco, Teresa, Feldman, Jeremy, Hemnes, Anna, Horn, Evelyn M., Lammi, Matthew, Mathai, Stephen, McConnell, John W., Presberg, Kenneth, Robinson, Jeffrey, Sager, Jeffrey, Shlobin, Oksana A., Simon, Marc, Thenappan, Thenappan, Ventetuolo, Corey, Al-Naamani, Nadine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Rationale: Obesity is associated with pulmonary arterial hypertension (PAH), but its impact on outcomes such as health-related quality of life (HRQoL), hospitalizations, and survival is not well understood. Objectives: To assess the effect of obesity on HRQoL, hospitalizations, and survival in patients with PAIL. Methods: We performed a cohort study of adults with PAH from the Pulmonary Hypertension Association Registry, a prospective multicenter registry. Multivariate linear mixed-effects regression was used to examine the relationship between weight categories and HRQoL using the Short Form-12 and emPHasis-10. We used multivariable negative binomial regression to estimate hospitalization incidence rate ratios (IRRs) and Cox regression to estimate hazard ratios (HRs) for transplant-free survival by weight status. Results: A total of 767 subjects were included (mean age of 57 years, 74% female, 33% overweight, and 40% with obesity), with median follow-up duration of 527 days. Overweight patients and patients with obesity had higher baseline emPHasis-10 scores (worse HRQoL), which persisted over time (P
ISSN:1546-3222
2329-6933
2325-6621
DOI:10.1513/AnnalsATS.202006-612OC